PAVmed Inc

+0.10 (+2.99%)
Earnings Announcements

PAVmed Says It No Longer Has To Raise Capital And Dilute Its Shareholders To Finance Lucid's Operations

Published: 11/16/2021 22:10 GMT
PAVmed Inc (PAVM) - Pavmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results.
No Longer Has to Raise and Spend Capital, and Dilute Its Shareholders, to Finance Lucid's Operations.
Co's Equity Stake in Lucid Increased to 76% Post-ipo on Converting Debt Into Equity Immediately Prior to Consummation of Ipo.
Q3 Preliminary Adjusted Non-GAAP Loss per Share $0.10.
Q3 Prelim GAAP Loss per Share $0.15.
Q3 Earnings per Share View $-0.13 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.48 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0.67 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.